Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Research Articles, Development/Plasticity/Repair

Sphingosine-1-Phosphate Signaling through Müller Glia Regulates Neuroprotection, Accumulation of Immune Cells, and Neuronal Regeneration in the Rodent Retina

Olivia Taylor, Lisa E. Kelly, Heithem M. El-Hodiri and Andy J. Fischer
Journal of Neuroscience 22 October 2025, 45 (43) e0150252025; https://doi.org/10.1523/JNEUROSCI.0150-25.2025
Olivia Taylor
1Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio 43210
2Neuroscience Graduate Program, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa E. Kelly
1Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heithem M. El-Hodiri
1Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy J. Fischer
1Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Patterns of expression of S1P-related genes in damaged mouse retinas. scRNA-seq was used to identify patterns of expression of S1P-related factors among retinal cells with the data presented in UMAP a–h or violin plots i. Aggregate scRNA-seq libraries were generated for cells from control retinas and retinas 3, 6, 12, 24, 36, 48, and 72 h after NMDA treatment. MG were bioinformatically isolated and analyzed from the large aggregate library (f–i). UMAP-ordered cells formed distinct clusters of neuronal cells, resting MG, activated MG, and returning to resting MG based on distinct patterns of gene expression (c). UMAP heatmap plots illustrate patterns and levels of expression of S1P receptors S1pr1, S1pr2, S1pr3, and S1P metabolism gene Sphk1 (h). Violin plots illustrate relative levels of expression in clusters of MG, activated MG, and returning to resting MG (i). Significance of difference was determined by using a Wilcox rank sum with Bonferroni’s correction (supplemental Table 1). Abbreviations: MG, Müller glia; NMDA, N-methyl-D-aspartate; UMAP, Uniform Manifold Approximation and Projection.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Fluorescence in situ hybridization (FISH) for S1PR1 and SPHK1. Glast-CreER:LNL-tTA:tetO-mAscl1-ires-GFP mice received intraperitoneal injections of tamoxifen or corn oil once daily for 4 consecutive days. Eyes received intravitreal injections with NMDA or saline, and retinas were collected 4 h after NMDA treatment. Retinal sections were labeled with antibodies to Sox2 (cyan), GFP (green), or FISH probes to S1pr1 (red puncta; a, c) or Sphk1 (red puncta; b). Regions of interest (yellow boxes) are enlarged 1.8-fold and displayed in adjacent channels. Solid arrows indicate Sox2+/GFPlow MG nuclei, and hollow arrows indicate Sox2+/GFPhigh MG nuclei. The area occupied by Sox2+ (b) or GFP+ cells (e), was selected to distinguish FISH puncta labeling within these regions. Small double arrows indicate endothelial cells. Scale bars: a, b, c, and e represent 50 µm. Histograms represent the mean (bar ± SD) number of FISH puncta per MG and each dot represents one biological replicate (d; n = 6 or 7). Significance of difference (p values) was determined by using a paired t test. Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NMDA, N-methyl-D-aspartate; ns, not significant.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Inhibition of S1P signaling enhances Ascl1-mediated reprogramming of MG into neurogenic progenitor cells. Schematic summary of S1P signaling and sites of action for different small molecule agonists and antagonists a, Glast-CreER:LNL-tTA:tetO-mAscl1-ires-GFP mice were intraperitoneally injected with tamoxifen or corn oil once daily for 4 d. Eyes were intravitreally injected NMDA and either a vehicle control or inhibitors to Sphk1 (PF543) and S1pr1/3 (VPC23019). At 24HPI, eyes were treated with vehicle or inhibitors. Eyes were treated with TSA at 48HPI. Retinas were collected 24 d from the first tamoxifen injection. Retinal sections were labeled with DAPI (blue, b, d) or EdU (blue, e, h) and antibodies to GFP (green) and Sox2 (red, b, d), Otx2 (red, e, h), Scgn (red, i), or Lhx4 (red, j). Regions of interest (yellow boxes) are enlarged 1.5 (b, d) or 2-fold (e, h, i, j) and displayed in separate panels. Solid arrows indicate GFP+/Sox2high cells in b and d, and hollow arrowheads indicate GFP+/Sox2low cells. In e and h, solid arrows indicate GFP+/Otx2+/EdU+ cells. Scale bars: b and e represent 50 µm. Histograms represent the mean (bar ± SD) where each dot represents one biological replicate (n = 8), and blue lines connect control and treated eyes from the same individual (c, g, f). Significance of difference (p values) was determined by using a paired t test. Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NMDA, N-methyl-D-aspartate; ns, not significant.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Cross-regulation of S1P/S1pr1 and NFκB signaling in MG. Retinas were obtained from undamaged or NMDA-injured eyes treated with a vehicle control or a small molecule agonist/antagonist a–g, Retinal sections were labeled with DAPI (e) and antibodies to Sox2 (red, a, c, e; pseudocolored cyan, f) and NFκB-GFP (green, a, c, e) or FISH probes to S1pr1 (red puncta; f). Arrows indicate the nuclei of MG. Scale bars: a, c, and f represent 50 µm. Regions of interest (yellow boxes) are enlarged 1.8-fold and displayed in separate panels (f). Histograms illustrate the mean (bar ± SD) number of NFκB-eGFP in MG (b, d) or number of FISH puncta per MG (g), where each dot represents one biological replicate (n = 5–8), and blue lines connect replicates from control and treated retinas from one individual. Significance of difference (p values) was determined by using a paired t test (b, d, g). Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; EdU, 5-ethynyl-2′-deoxyuridine; NMDA, N-methyl-D-aspartate; ns, not significant; UMAP, Uniform Manifold Approximation and Projection.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Immune cell accumulation in S1pr1 KO and Sphk1 KO retinas. Rlbp1-CreERT:S1pr1fl/fl and Rlbp1-CreERT:Sphk1fl/fl mice were intraperitoneally injected with tamoxifen or corn oil once daily for 4 d. Eyes were intravitreally injected with NMDA or saline control, and retinas were collected 48HPI. Retinal sections were labeled with antibodies to Iba1 (blue) and CD45 (green; a, b). Solid arrows indicate Iba1+/CD45+ cells, and hollow arrowheads indicate Iba1+/CD45− cells. Scale bars: a and b, represent 50 µm. Histograms represent the mean (bar ± SD) where each dot represents one biological replicate (c, d; n = 5–18). Significance of difference (p values) was determined by using ANOVA with Sidak’s correction. Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NMDA, N-methyl-D-aspartate; ns, not significant.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    cKO of S1pr1 from MG is neuroprotective to retinal ganglion cells. Sections of the retina were labeled for fragmented DNA (TUNEL; green; a) and DAPI (blue), or Brn3a (green; d), tdTomato (red) and DAPI (blue), HuC/D (green; f), tdTomato (red) and DAPI (blue), or Pax6 (green, i), tdTomato (red), and DAPI (blue). Arrows indicate TUNEL+ nuclei (a) or Brn3a+ nuclei (d) or HuC/D+ cells (f) and small double arrows indicate GFP+ endothelial cells. Scale bars: a, d, and f, represent 50 µm. Histograms represent the mean (bar ± SD) where each dot represents one biological replicate (b, c, e, g, h, j; n = 5–10). Significance of difference (p values) was determined by using ANOVA with Sidak’s correction. Abbreviations: ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NMDA, N-methyl-D-aspartate; ns, not significant; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    cKO of Sphk1 from MG is neuroprotective to inner retinal neurons. Sections of the retina were labeled for fragmented DNA (TUNEL; green; a) and DAPI (blue), or Brn3a (green; d), tdTomato (red) and DAPI (blue), or HuC/D (green; f), tdTomato (red) and DAPI (blue), or Pax6 (green; h), tdTomato (red) and DAPI (blue). Single arrows indicate TUNEL+ nuclei (a) or Brn3a+ nuclei (d) or HuC/D+ cells (f), and small double arrows indicate GFP+ endothelial cells. Scale bars: a, d, f, and h represent 50 µm. Histograms represent the mean (bar ± SD) where each dot represents one biological replicate (b, c, e, g, i; n = 6–8). Significance of difference (p values) was determined by using ANOVA with Sidak’s correction. ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NMDA, N-methyl-D-aspartate; ns, not significant; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Schematic summary of findings. Sphk1, S1pr1, and S1pr3 are expressed in MG. In the current study, we provide evidence that S1pr1 activity in MG suppresses Ascl1-mediated reprogramming, inhibits neurotrophic activity, and stimulates NFκB activation in the damaged retina. Astrocytes, endothelial cells, and immune cells express components of the S1P pathway, which may interact with S1P:S1pr1 signaling in MG to influence reprogramming, neuroprotection, and inflammation.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1.

    Pharmacological compounds

    Drug NameDoseSourceCatalog #Vehicle
    Sphingosine-1 phosphate (d18:1)2 ugCayman62570Saline 1% BSA
    Amiselimod (MT1303)2 ugCayman20970DMSO
    CYM54422 ugCayman16925DMSO
    Fingolimod (FTY720)2 ugSigmaSML0700DMSO
    NIBR02131 ugCayman21513DMSO
    NMDA14.7 ugSigmaM3262Saline
    PF-543 (hydrochloride)2 ugCayman17034DMSO
    S1PL-in-311 ugAobiousAOB31664DMSO
    Sphingosine-1 phosphate (d18:1)2 ugCayman62570DMSO
    SEW28712 ugCayman10006440DMSO
    Trichostatin A1 ugSigmaT8552DMSO
    TY 521562 ugCayman19119DMSO
    VPC 230192 ugCayman13240DMSO
    • View popup
    Table 2.

    Antibodies

    AntibodyDilutionHostSourceClone/catalog number
    Brn3a1:50MouseMilliporeMAB1585
    CD451:300RatBio-RadMCA1031G
    cFos1:500RabbitCell Signaling2250
    GFP1:1,000ChickenAbcamAb13970
    HuD/C1:300MouseInvitrogenA21271
    Iba11:500RabbitWako019–19741
    Lhx41:300RabbitProteintech11183-1-ap
    PAX61:1,000RabbitBioLegend901301
    pERK1/21:500RabbitCell Signaling4370
    pS61:500RabbitCell Signaling2215
    Scgn1:500RabbitCell Signaling14037
    Sox21:1,000GoatR&D SystemsKOY0418121
    S1pr11:1,000RabbitNovus BiologicalsNB120-11424
    S1pr11:500MouseR&D SystemsMAB7089
    S1pr11:500MouseSanta CruzSc-48356
    Sphk11:1,000RabbitBioss Antibodiesbs-2652R
    Sphk11:500RabbitCell Signaling12071
    • View popup
    Table 3.

    Pharmacological compounds, cKO, and effects

    Drug NameExpected site of actionExpected actionExpected action on S1P signalingEffect on NFkB reporter in MGEffect of MAPK signaling in MGEffect on neuronal differentiation (Ascl1-OE)Effect on cell death (INL/GCL)References for actions and specificity
    Sphingosine-1 phosphateS1pr1/3Activator↑↑↔N/IN/IAlvarez et al. (2010b)
    SEW2871S1pr1Activator↑↑↑N/IN/IHale et al. (2004); Sanna et al. (2004)
    CYM5442S1pr1Activator↑↑N/IN/IN/IGonzalez-Cabrera et al. (2008); Janes et al. (2014)
    Amiselimod (MT1303)S1pr1Inhibitor↓↓↔NI↔Shimano et al. (2019)
    NIBR0213S1pr1Inhibitor↓↓N/IN/I↓ / ↓Huwiler et al. (2000); Quancard et al. (2012)
    Fingolimod (FTY720)S1pr1Activate then downregulate receptor↓N/IN/IN/I↔/ ↓Brinkmann et al. (2010); Chun et al. (2021b)
    TY 52156S1pr3Inhibitor↓N/IN/IN/IN/IMurakami et al. (2010); Hirata et al. (2014)
    VPC 23019S1pr1/3Inhibitor↓N/IN/I↑ combined with PF543N/IDavis et al. (2005); Aoki et al. (2007); Mihovilovic et al. (2007)
    PF-543Sphk1Inhibitor↓↓↔↑ combined with VPC23019↓ / ↓Schnute et al. (2012, 2017)
    S1PL-in-31Sgpl1Inhibitor↑↑N/IN/I↑ / ↔Weiler et al. (2014); Harris et al. (2016)
    PGJ2IkB Kinase (IKK)Inhibitor↑ increased levels of S1pr1↓N/IN/I↓ / ↓Straus et al. (2000); Palazzo et al. (2022b)
    cKO S1pr1S1pr1cKO from MG↓N/IN/IN/I↓ / ↔
    cKO Sphk1Sphk1cKO from MG↓N/IN/IN/I↓ / ↓
    • ↑, increase; ↓, decrease; ↔, no difference; N/I, not investigated.

Additional Files

  • Figures
  • Tables
  • Supplemental Material

    • JN-RM-0150-25-suppl.pdf
Back to top

In this issue

The Journal of Neuroscience: 45 (43)
Journal of Neuroscience
Vol. 45, Issue 43
22 Oct 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sphingosine-1-Phosphate Signaling through Müller Glia Regulates Neuroprotection, Accumulation of Immune Cells, and Neuronal Regeneration in the Rodent Retina
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Sphingosine-1-Phosphate Signaling through Müller Glia Regulates Neuroprotection, Accumulation of Immune Cells, and Neuronal Regeneration in the Rodent Retina
Olivia Taylor, Lisa E. Kelly, Heithem M. El-Hodiri, Andy J. Fischer
Journal of Neuroscience 22 October 2025, 45 (43) e0150252025; DOI: 10.1523/JNEUROSCI.0150-25.2025

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Sphingosine-1-Phosphate Signaling through Müller Glia Regulates Neuroprotection, Accumulation of Immune Cells, and Neuronal Regeneration in the Rodent Retina
Olivia Taylor, Lisa E. Kelly, Heithem M. El-Hodiri, Andy J. Fischer
Journal of Neuroscience 22 October 2025, 45 (43) e0150252025; DOI: 10.1523/JNEUROSCI.0150-25.2025
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Data Availability
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • immune cell recruitment
  • MG-derived progenitor cells (MGPCs)
  • Müller glia
  • NFκB signaling
  • retinal injury
  • sphingosine-1-phosphate (S1P)

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Increased perceptual reliability reduces membrane potential variability in cortical neurons
  • Synergistic geniculate and cortical dynamics facilitate a decorrelated spatial frequency code in the early visual system
  • Is the whole the sum of its parts? Neural computation of consumer bundle valuation in humans
Show more Research Articles

Development/Plasticity/Repair

  • Activity Deprivation Modulates the Shank3/Homer1/mGluR5 Signaling Pathway to Enable Synaptic Upscaling
  • IGFBP2–Ceramide Pathway Mediates Divergent Myelin Breakdown in the PNS and CNS Following Injury
  • Smg5 Enhances Oligodendrocyte Differentiation via Nonsense-Mediated mRNA Decay of Hnrnpl Variant Transcripts
Show more Development/Plasticity/Repair
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.